Evidence map›Paper›PMID 39940106›Full record

ReviewThe FEBS journal2025

A signal transduction blind spot: the function of adenylyl cyclase transmembrane domains.

Ryan S Dowsell, Matthew G Gold

Abstract readReview
In one paragraph

Review in The FEBS journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ryan S DowsellDepartment of Neuroscience, Physiology & Pharmacology, University College London, UK.
Matthew G GoldDepartment of Neuroscience, Physiology & Pharmacology, University College London, UK.ORCID https://orcid.org/0000-0002-1281-0815

Funding

Biotechnology and Biological Sciences Research Council BB/X008215/1Wellcome Trust
6 · The paper itself

Abstract

Signal transduction of external primary signals into intracellular elevations of the second messenger cyclic AMP is an ancient and universal regulatory mechanism in biology. In mammals, 9 of the 10 adenylyl cyclases (ACs) share a common topology that includes a large transmembrane (TM) domain assembled from two clusters of six helices. This domain accounts for ~ 35% of the coding sequence but, remarkably, its function is still an open question. In this viewpoint, we consider how the first primary AC sequences spurred ideas for the purpose of AC TM domains, including voltage-sensing and transporter functions. In the original conceptions of second messenger signalling, ACs were put forward as potential receptors, and we discuss emerging evidence in support of this function. We also consider growing evidence that cyclase TM helical bundles help to organise multiprotein signalling complexes by engaging in interactions with other membrane-embedded proteins. Cyclase TM regions are more diverse between isoforms than the catalytic domain-we conclude by considering how this might be exploited in therapeutic strategies targeting specific cyclase isoforms.

Indexed as

Adenylyl CyclasesSignal TransductionAnimalsCell MembraneCyclic AMPHumansProtein DomainsSecond Messenger SystemsAdenylyl CyclasesCyclic AMPadenylyl cyclasecAMPprotein–protein interactionsignal transductiontransmembrane domain

Identifiers

PMID39940106
PMCPMC12414865

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.